224 related articles for article (PubMed ID: 9563006)
1. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells.
Falany JL; Falany CN
Oncol Res; 1997; 9(11-12):589-96. PubMed ID: 9563006
[TBL] [Abstract][Full Text] [Related]
2. Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells.
Kotov A; Falany JL; Wang J; Falany CN
J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):137-44. PubMed ID: 10369411
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines.
Falany JL; Falany CN
Cancer Res; 1996 Apr; 56(7):1551-5. PubMed ID: 8603401
[TBL] [Abstract][Full Text] [Related]
4. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
[TBL] [Abstract][Full Text] [Related]
5. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells.
Qian Y; Deng C; Song WC
J Pharmacol Exp Ther; 1998 Jul; 286(1):555-60. PubMed ID: 9655902
[TBL] [Abstract][Full Text] [Related]
7. Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines.
Chetrite GS; Paris J; Shields-Botella J; Philippe JC; Pasqualini JR
Anticancer Res; 2003; 23(6C):4651-5. PubMed ID: 14981909
[TBL] [Abstract][Full Text] [Related]
8. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
9. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
10. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
11. New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase.
Sasano H; Nagasaki S; Miki Y; Suzuki T
Ann N Y Acad Sci; 2009 Feb; 1155():76-9. PubMed ID: 19250194
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation.
Falany JL; Macrina N; Falany CN
Breast Cancer Res Treat; 2002 Jul; 74(2):167-76. PubMed ID: 12186377
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
15. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
16. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.
Mutoh K; Tsukahara S; Mitsuhashi J; Katayama K; Sugimoto Y
Cancer Sci; 2006 Nov; 97(11):1198-204. PubMed ID: 16925584
[TBL] [Abstract][Full Text] [Related]
18. Recovery of cellular E-cadherin precedes replenishment of estrogen receptor and estrogen-dependent proliferation of breast cancer cells rescued from a death stimulus.
Malaguti C; Rossini GP
J Cell Physiol; 2002 Aug; 192(2):171-81. PubMed ID: 12115723
[TBL] [Abstract][Full Text] [Related]
19. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
Zheng ZY; Lin VC
Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
[TBL] [Abstract][Full Text] [Related]
20. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
